PATCHLESS PATCH
DEAD

Serial Number

78288099

Owner

ACRUX DDS PTY LTD

Attorney

STEPHEN A. BENT

Filing Date

Aug 15, 2003

Add to watchlist:

No watchlists yet
View on USPTO

PATCHLESS PATCH Trademark

Serial Number: 78288099 • Registration: 3062095

PATCHLESS PATCH is a trademark filed by ACRUX DDS PTY LTD on August 15, 2003. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

ACRUX DDS PTY LTD (12 trademarks)

103-113 STANELY STREET
WEST MELBOURNE, VIC 3003 , AU

Entity Type: 11

Trademark Details

Filing Date

August 15, 2003

Registration Date

February 28, 2006

Published for Opposition

December 6, 2005

Cancellation Date

October 5, 2012

Goods & Services

Pharmaceutical and veterinary preparations for the treatment of symptoms of menopause, female androgen insufficiency, severe pain, for the treatment of central nervous system disorders including nausea and anxiety-related disorders, male androgen insufficiency, urinary incontinence, for contraception and smoking cessation; pharmaceutical compositions for transdermal delivery for the treatment of symptoms of menopause, female androgen insufficiency, severe pain, for the treatment of central nervous system disorders including nausea and anxiety-related disorders, male androgen insufficiency, urinary incontinence, for contraception and smoking cessation; pharmaceutical compositions for transmucosal delivery for the treatment of symptoms of menopause, female androgen insufficiency, severe pain, for the treatment of central nervous system disorders including nausea and anxiety-related disorders, male androgen insufficiency, urinary incontinence, for contraception and smoking cessation; pharmaceutical compositions for hormone-replacement therapy; pharmaceutical compositions containing active agents for the treatment of diseases and conditions of the central nervous system; pharmaceutical compositions for non-occlusive transdermal and transmucosal delivery which form a reservoir or deposit within the skin or membrane for the treatment of symptoms of menopause, female androgen insufficiency, severe pain, for the treatment of central nervous system disorders including nausea and anxiety-related disorders, male androgen insufficiency, urinary incontinence, for contraception and smoking cessation; pharmaceutical compositions providing transdermal and transmucosal delivery of hormones such as estradiol and other physiologically active agents acting on the central nervous system such as fentanyl

Filing History

CANCELLED SEC. 8 (6-YR)
Oct 5, 2012 C8..
REGISTERED-PRINCIPAL REGISTER
Feb 28, 2006 R.PR
PUBLISHED FOR OPPOSITION
Dec 6, 2005 PUBO
NOTICE OF PUBLICATION
Nov 16, 2005 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Oct 14, 2005 PREV
ASSIGNED TO LIE
Sep 16, 2005 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 10, 2005 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 9, 2005 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 6, 2005 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 6, 2005 TROA
NON-FINAL ACTION MAILED
Mar 7, 2005 CNRT
NON-FINAL ACTION WRITTEN
Mar 6, 2005 CNRT
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 19, 2004 CRFA
AMENDMENT FROM APPLICANT ENTERED
Nov 17, 2004 ACEC
PAPER RECEIVED
Nov 9, 2004 MAIL
AMENDMENT FROM APPLICANT ENTERED
Sep 16, 2004 ACEC
ASSIGNED TO LIE
Sep 16, 2004 ALIE
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 17, 2004 CRFA
PAPER RECEIVED
Aug 17, 2004 MAIL
NON-FINAL ACTION MAILED
Feb 17, 2004 CNRT
ASSIGNED TO EXAMINER
Jan 30, 2004 DOCK
PAPER RECEIVED
Nov 17, 2003 MAIL